{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:39:46Z","timestamp":1791257986588,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"DOI":"10.1309\/ajcpebk31vqqnddr","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T15:23:52Z","timestamp":1379431432000},"page":"536-543","source":"Crossref","is-referenced-by-count":56,"title":["CD200 Flow Cytometric Assessment and Semiquantitative Immunohistochemical Staining Distinguishes Hairy Cell Leukemia From Hairy Cell Leukemia-Variant and Other B-Cell Lymphoproliferative Disorders"],"prefix":"10.1093","volume":"140","author":[{"given":"Vinodh","family":"Pillai","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pozdnyakova","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karry","family":"Charest","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliakbar","family":"Shahsafaei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Dorfman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"key\n\t\t\t\t20180602031252_b1-1400536","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00404426","article-title":"Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein","volume":"25","author":"McCaughan","year":"1987","journal-title":"Immunogenetics"},{"key":"key\n\t\t\t\t20180602031252_b2-1400536","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"key":"key\n\t\t\t\t20180602031252_b3-1400536","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX-2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science"},{"key":"key\n\t\t\t\t20180602031252_b4-1400536","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.4049\/jimmunol.171.6.3034","article-title":"Characterization of the CD200 receptor family in mice and humans and their interactions with CD200","volume":"171","author":"Wright","year":"2003","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180602031252_b5-1400536","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","author":"Moreaux","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602031252_b6-1400536","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.leu.2404559","article-title":"CD200 as a prognostic factor in acute myeloid leukemia","volume":"21","author":"Tonks","year":"2007","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602031252_b7-1400536","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2007.11.103","article-title":"CD200: a putative therapeutic target in cancer","volume":"366","author":"Moreaux","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180602031252_b8-1400536","first-page":"3922","article-title":"CD200 is induced by ERK and is a potent therapeutic target in melanoma","volume":"117","author":"Petermann","year":"2007","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180602031252_b9-1400536","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1073\/pnas.0510081103","article-title":"Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation","volume":"103","author":"McWhirter","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180602031252_b10-1400536","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.178.9.5595","article-title":"CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy","volume":"178","author":"Kretz-Rommel","year":"2007","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180602031252_b11-1400536","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/AJCP38XRRUGSQOVC","article-title":"CD200 (OX-2 membrane glycoprotein) expression in B cell\u2013derived neoplasms","volume":"134","author":"Dorfman","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602031252_b12-1400536","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2009.07644.x","article-title":"CD200\/OX2, a cell surface molecule with immune-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells","volume":"145","author":"Brunetti","year":"2009","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602031252_b13-1400536","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cell and angioimmunoblastic T-cell lymphoma","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602031252_b14-1400536","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1309\/AJCP62WRKERPXDRT","article-title":"Germinal center T helper cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma","volume":"131","author":"Yu","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602031252_b15-1400536","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAS.0b013e31820065c9","article-title":"CD200 (OX-2 membrane glycoprotein) is expressed by follicular T helper cells and in angioimmunoblastic T cell lymphoma","volume":"35","author":"Dorfman","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602031252_b16-1400536","volume-title":"WHO classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"key\n\t\t\t\t20180602031252_b17-1400536","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9440(10)64287-3","article-title":"Loss of expression of the WNT\/\u03b2-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor (TCF-1) in a subset of peripheral T cell lymphomas","volume":"162","author":"Dorfman","year":"2003","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180602031252_b18-1400536","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1309\/AQQ2DVM75DVY0PWP","article-title":"T-bet, a T-cell\u2013associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders","volume":"122","author":"Dorfman","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602031252_b19-1400536","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2004.10.006","article-title":"T-bet, a T-cell\u2013associated transcription factor, is expressed in Hodgkin\u2019s lymphoma","volume":"36","author":"Dorfman","year":"2005","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602031252_b20-1400536","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1309\/AJCP2F2DOXOTXHZA","article-title":"The diagnostic value of CD1d expression in a large cohort of patients with B-cell chromic lymphoproliferative disorders","volume":"136","author":"Kotsianidis","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602031252_b21-1400536","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1309\/AJCPL13YDUHFKPJU","article-title":"Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders","volume":"131","author":"Dong","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602031252_b22-1400536","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Palumbo","year":"2009","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t20180602031252_b23-1400536","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","author":"Alapat","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602031252_b24-1400536","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.180.2.699","article-title":"Blockade of CD200 in the presence or absence of antibody effector function: implications of anti-CD200 therapy","volume":"180","author":"Kretz-Rommel","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180602031252_b25-1400536","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14712598.8.1.5","article-title":"Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression","volume":"8","author":"Kretz-Rommel","year":"2008","journal-title":"Expert Opin Biol Ther"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/140\/4\/536\/24994909\/ajcpath140-0536.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:59:59Z","timestamp":1563929999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/140\/4\/536\/1761001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,10,1]]},"published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpebk31vqqnddr","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,10,1]]},"published":{"date-parts":[[2013,10,1]]}}}